[1]
H. Soytürk, Ş. Karabörk, and Ş. Aydın Türkoğlu, “Investigation of IL-17A, IL-17F, IL-34 Levels of Patient with Multiple Sclerosis and Pseudotumor Cerebri”, Acta Medica, vol. 52, no. 2, pp. 114–121, Jun. 2021.